Cargando…
Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
Malignant gliomas are associated with a high mortality rate. Thus, there is an urgent need for the development of novel targeted therapeutics. Aberrant Hedgehog signaling has been directly linked to glioma. GDC-0449 is a novel small molecule inhibitor of Hedgehog signaling that blocks the activity o...
Autores principales: | Tu, Yiming, Niu, Mingshan, Xie, Peng, Yue, Chenglong, Liu, Ning, Qi, Zhenglei, Gao, Shangfeng, Liu, Hongmei, Shi, Qiong, Yu, Rutong, Liu, Xuejiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307388/ https://www.ncbi.nlm.nih.gov/pubmed/28195165 http://dx.doi.org/10.1038/srep42630 |
Ejemplares similares
-
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
por: Liu, Xuejiao, et al.
Publicado: (2016) -
FoxR2 promotes glioma proliferation by suppression of the p27 pathway
por: Liu, Xuejiao, et al.
Publicado: (2017) -
High expression of Bruton’s tyrosine kinase (BTK) is required for EGFR-induced NF-κB activation and predicts poor prognosis in human glioma
por: Yue, Chenglong, et al.
Publicado: (2017) -
Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway
por: Shan, Qianqian, et al.
Publicado: (2020) -
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation
por: Liu, Xuejiao, et al.
Publicado: (2020)